 |
 |
 |
 |
 |
 |
| July 2011 John attended the 2nd International NanoMedicine Conference in Sydney and presented "Commercialisation Australia - a new approach to technology commercialisation" | |
| June 2011 In the Press - "HypoMon Clinical Studies" Vodcast Mr Victor Skaldnev, CEO of Commercialisation Australia grant participant, AiMedics Pty Ltd, speaks about their hypoglycaemia medical device for diabetic patients, Commercialisation Australia and the supportive role of AiMedics' Case Manager, John Grew. http://www.commercialisationaustralia.gov.au/OurParticipants/Pages/AiMedics%20Pty%20Ltd.aspx In the Press - "Neuclone Licensing Deal" Dr Noelle Sunstrom, CEO of CHO cell platform company Neuclone Pty Ltd, announced a licensing deal with Lupin Pharmaceutical, one of India's largest generic pharmaceutical manufacturers. "Dr Sunstrom praised the Commercialisation Australia program, and in particular the independent advice and support during the negotiations process from NeuClone’s Commercialisation Australia Case Manager, Mr John Grew". http://www.commercialisationaustralia.gov.au/OurParticipants/Pages/NeuClone%20Pty%20Ltd.aspx | |
| November 2010 In the Press - Avexa gets $66M future Public listed HIV and infectious disease R&D company, Avexa Limited reported to shareholders the findings of an independent review of technical programme commercialisation and strategic direction by the bioadvisory group pty ltd.( BioTechnologyNews, 18 November 2010) http://www.biotechnologynews.net/StoryView.asp?StoryID=1542723 |
June 2010
the bioadvisory group pty ltd has been appointed by Commercialisation Australia (CA) to provide advisory and support services to CA grant applicants and successful participants. John has been appointed a national Case Manager with specific responsibility for NSW and ACT.
Commercialisation Australia is a federal government initiative designed to help innovative SME bridge the gap between R&D and Commercial success. A feature of the programme is the access to Case Managers and mentors with extensive domain expertise and deep commercialisation experience.
See www.commercialisationaustralia.gov.au for programme details and conditions, or contact the bioadvisory group.
March 2010
The company attended NZBIO in Auckland (22-24 March) where John presented a paper on "Animal Tissue Sharing Models in New Zealand".
